new post
StocksRunner logo
mail
search
 
menu
 
ImmunityBio
$8.26
-4.67%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

IBRX Stock Analysis & IQ Rating | ImmunityBio

 
 

IBRX

 

ImmunityBio

$8.26

 
-$0.41 | -4.67%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$12.43
 
 
MKT CAP
$8.55B
 
52W Low
$1.83
 
 
VOL
$12.32M
 
P/E Ratio
N/A
 
 
AVG VOL
$37.39M
 
RSI
52.10
 
 
TREND
Uptrend
 
 
 

IBRX Stock IQ

 
lock  Login to see ImmunityBio (IBRX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

IBRX Target Price

 
 
 

Strengths

 
 

IBRX Rewards

 Earnings are forecast to grow

IBRX Rewards

 Upgraded on attractively valued

 
 

IBRX Price Performance

 
 

$6.93   (+19.19%)

$2.3   (+259.13%)

$2.48   (+233.06%)

$2.85   (+189.82%)

 
 
1year
6month
3month
1month

IBRX Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

IBRX Earnings Sentiment Revenue increase YoY
IBRX Earnings Sentiment Reported a strong earnings
IBRX Earnings Sentiment Above analyst estimates

Rating

×

Rating

IBRX Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

IBRX Momentum Analysis Has been gaining momentum

Activity

×

Activity

Future

×

Future

IBRX Future Sentiment Earnings are forecast to grow
IBRX Analysts Opinion

IBRX Analysts opinion is positive and also has improved from the past 3 months

IBRX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

94%
Consensus Rating
100%
Buy
Opinion
91%
Trend
Score
100%
Potential
Score
IBRX Street Sentiment

IBRX Street Sentiment is extremely bullish and have positive views on the near-term outlook

IBRX Risk Level

IBRX has Low risk level

Risk Indicators

High volatilty
IBRX Risk Level
Low
LOW
HIGH

IBRX Performance Sentiment

Sentiments overview associated with events and the stock performance

94%
Positive
31 out of 33
events present
6%
Negative
2 out of 33
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$5.33
Resistance Price
$9.83
Current Price Range
$8.67
$5.33
$9.83
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
3
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Mar 06, 2026

 

Reiterate

 

Buy

 

H.C. Wainwright

 

Dec 17, 2025

 

Reiterate

 

Buy

 

D. Boral Capital

 

Dec 13, 2025

 

Reiterate

 

Buy

 

Jefferies

 

Dec 12, 2025

 

Reiterate

 

Buy

 

D. Boral Capital

 

Nov 14, 2025

 

Reiterate

 

Buy

 

D. Boral Capital

 
 
 
IBRX Latest Analysis +
 
 
FAQ About IBRX Stock Insights
 

What is IBRX current stock price?

What are IBRX stock strengths?

What is IBRX Risk Level?

What is IBRX market cap and volume?

What is IBRX current Stock IQ?

Should I buy IBRX stock right now?

Is IBRX a Strong Buy right now?

What does a 'Strong Buy' rating mean for IBRX?

What does a 'Strong Sell' rating mean for IBRX?

What factors influence IBRX's Stock IQ?

 
 
StocksRunner

Explore our IBRX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored IBRX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our IBRX Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

IBRX

 

ImmunityBio

 
Set Alerts
 
 

Current Price

 

$8.26

 
-$0.41 | -4.67%
 
 
52W High
$12.43
 
 
MKT CAP
$8.55B
 
52W Low
$1.83
 
 
VOL
$12.32M
 
P/E Ratio
N/A
 
 
AVG VOL
$37.39M
 
RSI
52.10
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 

Runners Also Watch

 
 
 
Symbol
Close
Change
 

CRSP

CRISPR Therapeutics

57.70

+2.12%

 

CLDI

Calidi Biotherapeutics In

0.36

-0.17%

 
 
 
 
 
user
 
 
 
 

IBRX Price Performance

 
 

$6.93   (+19.19%)

$2.3   (+259.13%)

$2.48   (+233.06%)

$2.85   (+189.82%)

 
 
1year
6month
3month
1month
 

IBRX Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

IBRX Earnings Sentiment Revenue increase YoY
IBRX Earnings Sentiment Reported a strong earnings
IBRX Earnings Sentiment Above analyst estimates

Rating

×

Rating

IBRX Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

IBRX Momentum Sentiment Has been gaining momentum

Activity

×

Activity

Future

×

Future

IBRX Future Sentiment Earnings are forecast to grow
IBRX Analysts Opinion

IBRX Analysts opinion is positive and also has improved from the past 3 months

IBRX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

94%
Consensus Rating
100%
Buy
Opinion
91%
Trend
Score
100%
Potential
Score
IBRX Street Sentiment

IBRX Street Sentiment is extremely bullish and have positive views on the near-term outlook

IBRX Risk Level

IBRX has Low risk level

Risk Indicators

High volatilty
IBRX Risk Level
Low
LOW
HIGH
IBRX Performance Sentiment
Sentiments overview associated with events and the stock performance.
94%
Positive
31 out of 33
events present
6%
Negative
2 out of 33
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$5.33
Resistance Price
$9.83
Current Price Range
$8.67
$5.33
$9.83
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
3
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Mar 06, 2026
Reiterate
Buy
H.C. Wainwright
Dec 17, 2025
Reiterate
Buy
D. Boral Capital
Dec 13, 2025
Reiterate
Buy
Jefferies
Dec 12, 2025
Reiterate
Buy
D. Boral Capital
Nov 14, 2025
Reiterate
Buy
D. Boral Capital
 
 
 
 

IBRX Stock IQ

 
 
 
lock  Login to unlock ImmunityBio (IBRX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

IBRX Rewards

 Earnings are forecast to grow

IBRX Rewards

 Upgraded on attractively valued

 
 
 

IBRX Latest Analysis

 
 
 

H.C. Wainwright Raised Its Price Target on ImmunityBio Inc. (IBRX) to $15 from $10 and Maintains a Buy Rating.

 

Fri Mar 6, 2026

$8.67 | -3.24%
 
Rating

ImmunityBio Inc. (IBRX) Price Target Raised After Strong ANKTIVA Launch. ImmunityBio Inc. (NASDAQ:IBRX) ranks among the most shorted stocks to buy according to analysts. H.C. Wainwright maintained a Buy rating for ImmunityBio Inc. (NASDAQ:IBRX) and increased its price target to $15 from $10 on February 23. According to the firm following ANKTIVAs United States introduction in 2025 ImmunityBio Inc. (NASDAQ:IBRX) reported that the medication brought in [….]

 

Wed Mar 4, 2026

$8.98 | -10.20%
 
Activity

ImmunityBio (IBRX) Loses 17% to Profit-Taking After Intra-Day High. We recently published 10 Stocks Left Behind in a Roaring Market. ImmunityBio Inc. (NASDAQ:IBRX) was one of the worst performers on Wednesday. ImmunityBio finished the session down sharply on Wednesday as investors resorted to profit-taking after touching a new record high during the day. At intra-day trading ImmunityBio Inc. (NASDAQ:IBRX) soared to its highest price [….]

 

Thu Feb 26, 2026

$9.55 | +0.10%
 
Momentum

ImmunityBio Supersedes Expectations With Fivefold Revenue Increase. ImmunityBio Inc. (NASDAQ:IBRX) shares are down on Wednesday cooling off from a huge up move as the company is reportedly experiencing significant revenue growth. This surge follows a strong performance driven by the sales of its lead drug Anktiva which has gained traction in the market.The stock has jumped over 50% over the last month thanks to investor interest after preliminary earnings and several strategic partnerships.Ankti

 

Wed Feb 25, 2026

$9.54 | -17.40%
 
Earnings

ImmunityBios 471% Stock Rally Could Enter Next Round If Shorts Capitulate. ImmunityBio Inc (NASDAQ:IBRX) has already delivered one of 2026'.s most explosive stock moves. But the conditions behind its 471% year-to-date surge suggest the most volatile phase may still lie ahead.Source: BenzingaIBRX stock surged nearly 86% in the past month alone driven by regulatory momentum and renewed investor focus on its cancer immunotherapy platform. The rally accelerated after regulatory progress tied to

 

Wed Feb 25, 2026

$9.54 | -17.40%
 
Momentum

ImmunityBio (IBRX) Reports 700% Revenue Surge Driven by Rapid ANKTIVA Adoption.

 

Wed Feb 25, 2026

$9.54 | -17.40%
 
Earnings

ImmunityBio (IBRX) Skyrockets as Anktiva Propels 671% Revenue Jump. We recently published 10 Stocks Winning the Market. ImmunityBio Inc. (NASDAQ:IBRX) was one of the best performers on Tuesday. ImmunityBio rallied for a sixth consecutive day on Tuesday to hit a nearly five-year high as investors continued to load portfolios thanks to a 671 percent revenue expansion last year driven by its bladder cancer treatment [….]

 

Wed Feb 25, 2026

$9.54 | -17.40%
 
Momentum
 
 
 
 
 
StocksRunner

Discover IBRX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of IBRX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our IBRX Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

IBRX Stock trends

IBRX Stock performance

IBRX Stock analysis

IBRX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

IBRX Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing IBRX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing IBRX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.